Tudor Investment Corp
TERN

Tudor Investment Corp’s Terns Pharmaceuticals TERN Stock Holding History

Tudor Investment Corp’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-267,520
Closed -$14.1M – 4264
2026
Q1 		$14.1M Buy
267,520
+194,274
+265% +$7.98M 0.03% 572
2025
Q4 		$2.96M Buy
+73,246
New +$1.69M 0.01% 1524
2024
Q4 		– Sell
-10,263
Closed -$85.6K – 3503
2024
Q3 		$85.6K Sell
10,263
-5,490
-35% -$45.2K ﹤0.01% 2601
2024
Q2 		$107K Buy
+15,753
New +$95.4K ﹤0.01% 2201

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tudor Investment Corp's TERN Position: Q2 2026 in Review

Tudor Investment Corp sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 267,520 shares — an estimated $14.1M sold.

Tudor Investment Corp first reported a position in TERN in Q2 2024 and held it in 4 quarters. The position peaked at $14.1M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Tudor Investment Corp reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 267,520 Terns Pharmaceuticals shares in Q2 2026, an estimated $14.1M.
  • Tudor Investment Corp first reported a position in Terns Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Tudor Investment Corp's Terns Pharmaceuticals position peaked at $14.1M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.